![]() Cell Genesys Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today. | ![]() Vitrolife Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. | ![]() Annexon Biosciences Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. | ![]() Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. | ||
Founding Date | Founding Date 2013 | Founding Date 1988 | Founding Date 1981 | Founding Date 2011 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Mont-Saint-Guibert, BE HQ | Locations Roosevelt, US HQ | Locations Västra Frölunda, SE HQ | Locations Brisbane, US HQ | Locations Cambridge, US HQ |
Employees | Employees 542% increase | Employees 89 | Employees 1,150 | Employees 10041% increase | Employees 43223% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) 799.8 m | Valuation ($) 202.2 m |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income (kr5b) (FY, 2025) | Net income ($206.7m) (FY, 2025) | Net income ($74.9m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 31.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 179m | Total funding raised $ 55m |

Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.
View company
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
View company
Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
View company
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View company